Effects Of Vitexin On Angiotensin II-Induced Kidney Injury And Its Relationship With The AT1R/Smad3 Pathway
Pakistan Journal of Pharmaceutical Sciences · 2026
DOI: 10.36721/pjps.2026.39.217.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Pharmaceutical Sciences, 2026. Verfasst von Yazhen Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Zhejiang Medical and Health Group Hangzhou Hospital, Hangzhou, Zhejiang, 310030, China. Hauptthemen laut MEDLINE: Apigenin, Smad3 Protein, Angiotensin II, Receptor, Angiotensin, Type 1. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Angiotensin II (Ang II)-induced kidney injury is a critical pathway in the progression of chronic kidney disease, with the AT1R/Smad3 signaling axis playing a well-established role. The natural flavonoid vitexin has shown multi-organ protective effects, but its role and mechanism in Ang II-induced renal injury remain unclear.
Objectives
To investigate the protective effect of vitexin against Ang II-induced kidney injury and explore whether its mechanism involves modulation of the AT1R/Smad3 pathway.
Methods
In-vitro, Ang II-induced HK-2 cell injury models were treated with vitexin (20 ?mol/L) or valsartan (1 ?mol/L). Cell viability and SOD activity were assessed. Protein levels of AT1R, Smad2/3, p-Smad2/3, and Smad7 were detected by Western blotting. In-vivo, C57BL/6 mice with Ang II-induced kidney injury (1.1 mg/kg/d, 21 days) received vitexin (60 mg/kg, every other day) or vehicle. Blood pressure, urinary protein/creatinine ratio, renal histopathology (HE, PAS, Masson staining) and expression of AT1R/Smad3 pathway components were evaluated.
Results
Vitexin significantly improved cell viability and SOD activity in HK-2 cells, comparable to valsartan. It downregulated AT1R, Smad2/3 and p-Smad2/3 while upregulating Smad7. In mice, vitexin lowered systolic blood pressure and the urinary protein/creatinine ratio, and alleviated renal histopathological damage, glomerular sclerosis, and fibrosis. It also reduced AT1R, p-Smad2/3, and CTGF expression and increased Smad7 in renal tissue.
Conclusion
Vitexin attenuates Ang II-induced kidney injury by modulating the AT1R/Smad3 signaling pathway, suggesting its potential as a therapeutic candidate for renal injury. Further studies are needed to validate causal mechanisms and pharmacokinetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Zhejiang Medical and Health Group Hangzhou Hospital, Hangzhou, Zhejiang, 310030, China.
- Cardiovascular Surgery, ZheJiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China.
- Department of Respiratory, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang, 310015, China.
Zitieren
APA
Huang, Y., Mao, W., Huang, Y., & Ge, H. (2026). Effects Of Vitexin On Angiotensin II-Induced Kidney Injury And Its Relationship With The AT1R/Smad3 Pathway. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps.2026.39.217.1
Vancouver
Huang Y, Mao W, Huang Y, Ge H. Effects Of Vitexin On Angiotensin II-Induced Kidney Injury And Its Relationship With The AT1R/Smad3 Pathway. Pakistan Journal of Pharmaceutical Sciences. 2026. doi:10.36721/pjps.2026.39.217.1
BibTeX
@article{Huang2026,
author = {Huang, Yazhen and Mao, Wenshuai and Huang, Yalu and Ge, Hong},
title = {Effects Of Vitexin On Angiotensin II-Induced Kidney Injury And Its Relationship With The AT1R/Smad3 Pathway},
journal = {Pakistan Journal of Pharmaceutical Sciences},
year = {2026},
doi = {10.36721/pjps.2026.39.217.1}
}
EUVIMED